Immune checkpoint blockade in melanoma: Advantages, shortcomings and emerging roles of the nanoparticles
Armita Mahdavi Gorabi, Mehrnaz Sadat Ravari, Mohammad‐Javad Sanaei, Soodabeh Davaran, Prashant Kesharwani, Amirhossein Sahebkar
Topics & Concepts
IpilimumabMelanomaImmune checkpointContext (archaeology)Tumor microenvironmentMedicineImmune systemBlockadeImmunotherapyCancer researchAdverse effectImmunologyPharmacologyInternal medicineBiologyPaleontologyReceptorCancer Immunotherapy and BiomarkersCancer, Stress, Anesthesia, and Immune ResponseCAR-T cell therapy research